I agree.
All we can do in the interim is hope, wait and see.
News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-8
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
-0.001(1.23%) |
Mkt cap ! $82.94M | |||
| Open | High | Low | Value | Volume |
| 8.0¢ | 8.0¢ | 7.9¢ | $133.2K | 1.679M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 587500 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 511339 | 7 |
View Market Depth
| Last trade - 11.43am 01/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |